Related Experiment Videos
Cancer in thalassemia and other hemoglobinopathies
American Journal of Hematology
|January 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The longitudinal biomonitoring of residents living near the waste incinerator of Turin: Polycyclic Aromatic Hydrocarbon metabolites after three years from the plant start-up.
Environmental pollution (Barking, Essex : 1987)·2022
Extramedullary hematopoiesis in the facial sinus in a patient homozygous for Hemoglobin Lepore: the first case in literature.
European review for medical and pharmacological sciences·2021
Retinal vein occlusion in child with rare mutations in genes for thrombophilia.
La Clinica terapeutica·2019
Primary Plasma Cell Leukemia.
American journal of hematology·2026
Real-World Outcomes of Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: The PETHRATIFY Study.
American journal of hematology·2026
HOPE Kids 2: Phase 3, Randomized Trial of Voxelotor in Children With SCD and Conditional Cerebral Blood Flow Velocities.
American journal of hematology·2026
Targeting B-Cell-Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia.
American journal of hematology·2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).
American journal of hematology·2026
Serum Retinol-Binding Protein 4 Levels in Hypertensive and Normotensive Individuals.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP·2026
Hereditary angioedema in women: Hormonal and reproductive influences on disease activity.
Allergy and asthma proceedings·2026
Outcomes of patients with myelofibrosis treated with ruxolitinib and anemia-supporting medications.
Hematology (Amsterdam, Netherlands)·2026
Conditioning Intensity and Outcomes in Pediatric HLA-Identical Transplant for Sickle Cell Disease: Comparison of MAC, RIC, and NMA.
Transplantation and cellular therapy·2026